SRPT in the 13F filings
Sarepta Therapeutics Inc · CUSIP 803607100
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 15 Aug 2024
- latest of these filings; the earliest 9 Aug 2024
- Managers listing it
- 15
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 11 listed it in both
- Shares listed
- 12,497,398
- combined, among listed positions
- Reported value
- $2.0bn
- combined, at the quarter end
Among the 94 comparable managers: 8 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing SRPT in Q2 2024
15 of 15 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Investments LPexisting position · 541,794 shares now+199,112
- Balyasny Asset Management LLCexisting position · 532,918 shares now+23,713
- Woodline Partners LPnew position · 20,381 shares now+20,381
- ExodusPoint Capital Management LPexisting position · 117,215 shares now+12,062
- Winton Group Ltdnew position · 2,688 shares now+2,688
Reductions
- Wellington Management Group LLPexisting position · 2,061,526 shares now-1,184,272
- Janus Henderson Group Ltdexisting position · 3,815,368 shares now-1,076,049
- Millennium Management LLCexisting position · 572,275 shares now-301,872
- Farallon Capital Management LLCexisting position · 2,295,000 shares now-158,500
- Voloridge Investment Management LLCexisting position · 288,617 shares now-141,852
New positions and exits
New (2)
- Woodline Partners LP$3.2m
- Winton Group Ltd$425k
Exited (2)
- Bridgewater Associates LPwas $3.0m
- Soros Fund Management LLCwas $512k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $52m | n.a. | n.a. |
| Q3 2013 | 3 | $62m | n.a. | n.a. |
| Q4 2013 | 1 | $4.7m | n.a. | n.a. |
| Q1 2014 | 1 | $601k | n.a. | n.a. |
| Q2 2014 | 3 | $68m | n.a. | n.a. |
| Q3 2014 | 2 | $12m | n.a. | n.a. |
| Q4 2014 | 1 | $22m | n.a. | n.a. |
| Q1 2015 | 1 | $23m | n.a. | n.a. |
| Q2 2015 | 2 | $31m | n.a. | n.a. |
| Q3 2015 | 5 | $74m | n.a. | n.a. |
| Q4 2015 | 2 | $129m | n.a. | n.a. |
| Q1 2016 | 1 | $58m | n.a. | n.a. |
| Q2 2016 | 3 | $62m | n.a. | n.a. |
| Q3 2016 | 10 | $425m | n.a. | n.a. |
| Q4 2016 | 5 | $48m | n.a. | n.a. |
| Q1 2017 | 6 | $58m | n.a. | n.a. |
| Q2 2017 | 4 | $123m | n.a. | n.a. |
| Q3 2017 | 6 | $239m | n.a. | n.a. |
| Q4 2017 | 8 | $150m | n.a. | n.a. |
| Q1 2018 | 8 | $1.1bn | n.a. | n.a. |
| Q2 2018 | 20 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 10 | $2.6bn | n.a. | n.a. |
| Q4 2018 | 13 | $2.1bn | n.a. | n.a. |
| Q1 2019 | 11 | $2.4bn | n.a. | n.a. |
| Q2 2019 | 11 | $2.9bn | n.a. | n.a. |
| Q3 2019 | 8 | $1.2bn | n.a. | n.a. |
| Q4 2019 | 9 | $2.5bn | n.a. | n.a. |
| Q1 2020 | 11 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.6bn | n.a. | n.a. |
| Q3 2020 | 11 | $3.1bn | n.a. | n.a. |
| Q4 2020 | 13 | $4.0bn | n.a. | n.a. |
| Q1 2021 | 11 | $1.3bn | n.a. | n.a. |
| Q2 2021 | 9 | $1.0bn | n.a. | n.a. |
| Q3 2021 | 10 | $1.2bn | n.a. | n.a. |
| Q4 2021 | 13 | $1.2bn | n.a. | n.a. |
| Q1 2022 | 12 | $1.1bn | n.a. | n.a. |
| Q2 2022 | 13 | $946m | n.a. | n.a. |
| Q3 2022 | 21 | $1.8bn | n.a. | n.a. |
| Q4 2022 | 21 | $1.9bn | n.a. | n.a. |
| Q1 2023 | 20 | $2.3bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.8bn | n.a. | n.a. |
| Q3 2023 | 19 | $2.1bn | n.a. | n.a. |
| Q4 2023 | 12 | $1.3bn | 6 | 10 |
| Q1 2024 | 15 | $2.0bn | 9 | 5 |
| Q2 2024 | 15 | $2.0bn | 8 | 9 |
| Q3 2024 | 12 | $1.4bn | 7 | 5 |
| Q4 2024 | 9 | $1.2bn | 4 | 5 |
| Q1 2025 | 11 | $665m | 9 | 3 |
| Q2 2025 | 5 | $175m | 5 | 1 |
| Q3 2025 | 6 | $164m | 2 | 3 |
| Q4 2025 | 7 | $298m | 16 | 15 |
| Q1 2026 | 5 | $281m | 18 | 11 |
| Q2 2026 | 5 | $132m | 14 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
SRPT and LLY →SRPT and JNJ →SRPT and VRTX →Choose a stock to compare with SRPT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own SRPT, latest filings →Back to the 13F Explorer →